ClinicalTrials.gg
RecruitingNCT05445856METATONSUpdated Dec 5, 2023

Intraoperative Methadone for Postoperative Pain in Patients Undergoing Tonsillectomy

A Phase 4 interventional study of Methadone and Fentanyl in Postoperative Pain, sponsored by University of Aarhus. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-05.

Sponsored by University of Aarhus · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Nov 2022; still recruiting 3 years 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies testing methadone in Pain, Postoperative — 8 open to participants now, 8 under way, 3 of them phase 3. Methadone · Pain, Postoperative.

Planned enrollment
8th of 37
130 · median 75
Started
2022
the only one that year
Phase 4
21 of 37
4 open now
Registered
25th of 37
by date
Lead sponsor
5 of 37
University of Aarhus

Among the 37 studies testing methadone in Pain, Postoperative, this one is the 8th largest by planned enrollment, is the only one that started in 2022, is one of 21 in phase 4, and was the 25th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

8 of the 37 studies testing methadone in Pain, Postoperative are open now, in 2 countries. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

About methadone

Methadone: first FDA approval 1947 (DOLOPHINE HYDROCHLORIDE). What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies testing methadone in Pain, Postoperative, or all of them as a file.
02

Study summary

A randomized controlled trial evaluating the efficacy and safety of single-shot intraoperative methadone for postoperative pain in patients undergoing tonsillectomy. Fentanyl is used as an active comparator

Read the detailed description

This study is an investigator-initiated, prospective, randomised controlled trial with two arms: an intervention arm (methadone) and a control arm (fentanyl). Patients scheduled for tonsillectomy at Randers Regional Hospital, Denmark, will be approached for study participation.

Patients are randomised in a 1:1 ratio in blocks of varying sizes (between 4 and 8) to receive either intraoperative methadone or fentanyl. The randomisation assignment will be handled by the hospital pharmacy using a web-based central randomisation procedure (www.sealedenvelope.com).

The study drug will be prepared by the hospital pharmacy at Aarhus University Hospital and delivered as kits with identical appearance, marked with the randomization number (1-130). On the day of surgery, a kit will be opened and a 10 ml syringe with study drug (methadone 2 mg/ml or fentanyl 30 microgram/ml or ) will prepared by a health care professional (nurse or medical doctor not involved in the study or the treatment of patients). Once prepared, the blinded study drug will be given to and handled by one of the research team members and administered after induction of anesthesia and prior to surgery

The dose of the study drug will be administered as intravenous bolus dose in equipotent doses (0.2 mg/kg / 3 μg/kg) corresponding to 1 ml for every 10 kg of ideal body weight (women: height (cm) - 105. Men: height (cm) - 100)) after induction of anaesthesia and before the start of surgery.

Postoperative data will be obtained by reviewing hospital records, by interview and electronic questionnaires sent by email.

03

Conditions studied

  • Postoperative Pain

Browse trials for

Keywords

  • Postoperative pain
  • Methadone
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients (≥18 years) scheduled for elective tonsillectomy

Exclusion criteria

Exclusion Criteria:

  • American Society of Anaesthesiologists (ASA) physical status IV or V
  • Allergy to study drugs
  • Daily use of opioids 7 days prior to surgery
  • Inability to provide
  • Severe respiratory insufficiency
  • Heart failure
  • Acute alcohol intoxication/delirium tremens
  • Increased intracranial pressure
  • Acute liver disease
  • Liver insufficiency
  • Kidney insufficiency
  • Treatment with rifampicin
  • Treatment with any drug prolonging the -interval
  • Pregnancy (every female not using will be screened with urine human choriogonadotropin)
  • Breastfeeding
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

QT and QTc

On an ECG, the QT interval is the time the heart’s lower chambers take to activate electrically and recover in each beat. QTc is that time adjusted for heart rate (QTcF by Fridericia’s formula, QTcB by Bazett’s). Some medicines lengthen it, and a long QTc can raise the risk of a dangerous heart rhythm.

The study may name a correction formula and a limit in milliseconds, often around 450–480.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
130 participants (estimated)

Study arms

  • Experimental
    Methadone

    Single-shot intravenous methadone 0.2 mg/kg administered intraoperatively

    Drug: Methadone

  • Active comparator
    Fentanyl

    Single-shot intravenous fentanyl 3 microgram/kg administered intraoperatively

    Drug: Fentanyl

Interventions

  • Methadone is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

  • Fentanyl is administered as a single intravenous dose after induction of anesthesia and prior to initiation of surgery

06

What researchers measure

Primary outcomes

  1. Postoperative pain

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

    Time frame: On arrival at the post-anesthesia care unit

  2. Opioid consumption

    Cumulative postoperative opioid consumption in morphine equivalents

    Time frame: First 5 postoperative days

Secondary outcomes

  1. Postoperative pain

    Pain at swallowing (numeric rating scale (NRS) 0-10, lower scores are better outcomes)

    Time frame: 1, 2, 3, 5 and 7 days after surgery

  2. Opioid consumption

    Cumulative postoperative opioid consumption in morphine equivalents

    Time frame: 1 and 7 days after surgery

  3. Postoperative nausea and vomiting (none, mild, moderate, severe)

    Nausea and/or vomiting (PONV), proportion of patients with none or mild PONV

    Time frame: 1, 2 and 3 days after surgery

  4. Sedation

    Level of sedation (Ramsay Scale (1-4)), proportion of patients being co-operative, oriented and tranquil

    Time frame: 4 hours after surgery

07

Study locations

1 of 1 sites recruiting
  • Department of Anaesthesiology and Intensive Care
    Randers, Denmark
    Recruiting
08

References and documents

Publications

  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Deshur MA, Vender JS, Benson J, Newmark RL. Clinical Effectiveness and Safety of Intraoperative Methadone in Patients Undergoing Posterior Spinal Fusion Surgery: A Randomized, Double-blinded, Controlled Trial. Anesthesiology. 2017 May;126(5):822-833. doi: 10.1097/ALN.0000000000001609. PubMed 28418966 ↗
  • Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Marymont JH, Shear T, Parikh KN, Patel SS, Gupta DK. Intraoperative Methadone for the Prevention of Postoperative Pain: A Randomized, Double-blinded Clinical Trial in Cardiac Surgical Patients. Anesthesiology. 2015 May;122(5):1112-22. doi: 10.1097/ALN.0000000000000633. PubMed 25837528 ↗
  • Gottschalk A, Durieux ME, Nemergut EC. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg. 2011 Jan;112(1):218-23. doi: 10.1213/ANE.0b013e3181d8a095. Epub 2010 Apr 24. PubMed 20418538 ↗
  • Udelsmann A, Maciel FG, Servian DC, Reis E, de Azevedo TM, Melo Mde S. Methadone and morphine during anesthesia induction for cardiac surgery. Repercussion in postoperative analgesia and prevalence of nausea and vomiting. Rev Bras Anestesiol. 2011 Nov-Dec;61(6):695-701. doi: 10.1016/S0034-7094(11)70078-2. English, Multiple languages. PubMed 22063370 ↗

Individual participant data

Plan to share: Undecided — IPD will be shared upon reasonable request

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2022 (actual). Primary completion is estimated for Jan 2024, 14 months after the start.

Of 535 non-industry phase 4 interventional studies under Pain, Postoperative, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 32. This study's planned 14 months is below that.

Counting every sponsor, half of 545 studies reached it within 16 months; a quarter within 8 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 30, 2022
First posted
Jul 6, 2022
StartActual
Nov 28, 2022
Primary completionEst.
Jan 2024
CompletionEst.
Aug 2024
Last update
Dec 5, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05445856
Responsible party
Sponsor
First posted
Jul 6, 2022
Start date
Nov 28, 2022
Primary completion
Jan 2024 (estimated)
Completion
Aug 2024 (estimated)
Last update
Dec 5, 2023

Study contacts

Michael Bøndergaard, MD
Contact
michael.vinther@gmail.com
004578420510
Kristian Friesgaard, MD, PhD
Contact
k.friesgaard@me.com
00457842332
Lone Nikolajsen, PhD, DMSc
study chair · Aarhus University Hospital, Department of Anesthesia and Intensive Care

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Methadone

Start the discussion